ABEONA THERAPEUTICS INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate
ABEONA THERAPEUTICS INC. (ABEO) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate of 95.00% for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-13.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate · last filed 2022-05-13
- ABEONA THERAPEUTICS INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2022-03-31 was 95.00%, a 4.04% decline year-over-year.
- ABEONA THERAPEUTICS INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2021-09-30 was 92.00%, a 16.36% decline year-over-year.
- ABEONA THERAPEUTICS INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2021-06-30 was 97.00%, a 12.61% decline year-over-year.
- ABEONA THERAPEUTICS INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2021-03-31 was 99.00%, a 10.81% decline year-over-year.
- ABEONA THERAPEUTICS INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2021 was 96.00%, a 12.73% decline from fiscal 2020.
- ABEONA THERAPEUTICS INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2020 was 110.00%, a 1.85% increase from fiscal 2019.
- ABEONA THERAPEUTICS INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2019 was 108.00%, a 0.92% decline from fiscal 2018.
- ABEONA THERAPEUTICS INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2018 was 109.00%, a 1.80% decline from fiscal 2017.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 3 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 12 month |
|---|---|---|---|---|---|
| 2022-03-31 | 95.00% 10-Q · filed 2022-05-13 | ||||
| 2021-12-31 | 96.00% 10-K · filed 2022-03-31 | ||||
| 2021-09-30 | 92.00% 10-Q · filed 2021-11-15 | 97.00% 10-Q · filed 2021-11-15 | |||
| 2021-06-30 | 97.00% 10-Q · filed 2021-07-28 | 98.00% 10-Q · filed 2021-07-28 | |||
| 2021-03-31 | 99.00% 10-Q · filed 2022-05-13 | ||||
| 2020-12-31 | 110.00% 10-K · filed 2022-03-31 | ||||
| 2020-09-30 | 110.00% 10-Q · filed 2021-11-15 | 111.00% 10-Q · filed 2021-11-15 | |||
| 2020-06-30 | 111.00% 10-Q · filed 2021-07-28 | 111.00% 10-Q · filed 2021-07-28 | |||
| 2020-03-31 | 111.00% 10-Q · filed 2021-05-17 | ||||
| 2019-12-31 | 108.00% 10-K · filed 2021-03-24 | ||||
| 2019-09-30 | 103.00% 10-Q · filed 2020-11-09 | 108.00% 10-Q · filed 2020-11-09 | |||
| 2019-06-30 | 108.00% 10-Q · filed 2020-08-10 | 108.00% 10-Q · filed 2020-08-10 | |||
| 2019-03-31 | 109.00% 10-Q · filed 2020-05-06 | ||||
| 2018-12-31 | 109.00% 10-K · filed 2020-03-16 | ||||
| 2018-09-30 | 109.00% 10-Q · filed 2019-11-12 | 109.00% 10-Q · filed 2019-11-12 | |||
| 2018-06-30 | 109.00% 10-Q · filed 2019-08-09 | 109.00% 10-Q · filed 2019-08-09 | |||
| 2018-03-31 | 109.00% 10-Q · filed 2019-05-10 | 1.09% 10-Q · filed 2018-05-10 | |||
| 2017-12-31 | 111.00% 10-K · filed 2020-03-16 | ||||
| 2016-12-31 | 109.00% 10-K · filed 2019-03-18 | ||||
| 2014-09-30 | 102.00% 10-Q · filed 2014-11-14 | ||||
| 2013-06-30 | 102.00% 10-Q · filed 2014-08-14 | ||||
| 2012-09-30 | 96.00% 10-Q · filed 2012-11-14 | ||||
| 2012-06-30 | 96.00% 10-Q · filed 2012-08-14 | ||||
| 2011-09-30 | 123.00% 10-Q · filed 2012-11-14 | ||||
| 2011-06-30 | 119.00% 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |